196 related articles for article (PubMed ID: 34156675)
1. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma.
Liu DK; Yu S; Li JP; Song WW; Li JH
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3981-3989. PubMed ID: 34156675
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
3. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
4. miR-450b promotes cell migration and invasion by inhibiting SERPINB2 in oral squamous cell carcinoma.
Wang X; Nie X; Xu G; Gao J; Wang B; Yang J; Song G
Oral Dis; 2024 Mar; 30(2):376-389. PubMed ID: 36251494
[TBL] [Abstract][Full Text] [Related]
5. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
6. Upregulation of miR-519d-3p Inhibits Viability, Proliferation, and G1/S Cell Cycle Transition of Oral Squamous Cell Carcinoma Cells Through Targeting CCND1.
Zhang W; Hong W
Cancer Biother Radiopharm; 2024 Mar; 39(2):153-163. PubMed ID: 33052706
[No Abstract] [Full Text] [Related]
7. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
Li WJ; Li G; Liu ZW; Chen ZY; Pu R
Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.
Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
[TBL] [Abstract][Full Text] [Related]
9. Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p.
Zhong J; He C; Xu F; Xu X; Liu L; Xu M; Guo Z; Wang Y; Liao J; Li Y
J Orthop Surg Res; 2020 Sep; 15(1):374. PubMed ID: 32883329
[TBL] [Abstract][Full Text] [Related]
10. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
Wang C; Wang Q; Weng Z
Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069
[TBL] [Abstract][Full Text] [Related]
11. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
Li C; Lin XF; Wang JN; Ren XS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
[TBL] [Abstract][Full Text] [Related]
12. FOXN3 Expression Regulated by miR-299-5p Inhibiting the Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells.
Maimaitiming K; Yilihamu A; Keyimu K; Keranmu R; Li J; Xu H; Wufuer D
Protein Pept Lett; 2022; 29(9):788-795. PubMed ID: 35975858
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).
Wang H; Jiang Z; Chen H; Wu X; Xiang J; Peng J
Med Sci Monit; 2017 Feb; 23():640-648. PubMed ID: 28159956
[TBL] [Abstract][Full Text] [Related]
14. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
15. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract][Full Text] [Related]
17. MiR-4282 inhibits tumor progression through down-regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma.
Zhang Y; Zhang Z; Huang W; Zeng J
J Cell Physiol; 2020 Nov; 235(11):8035-8047. PubMed ID: 31970774
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
19. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
